• Caitlin G Allen, Colleen Donahue, Emma Coen, Kiersten Meeder, Kristin Wallace, Cathy Melvin, Brian Neelon, and Kevin Hughes.
• Department of Public Health Sciences, College of Medicine, Medical University of South Carolina, Charleston, South Carolina. Electronic address: allencat@musc.edu.
• Am J Prev Med. 2024 Mar 1; 66 (3): 503515503-515.

IntroductionCurrently, no standard workflow exists for managing patients with pathogenic variants that put them at higher risk for hereditary cancers. Therefore, follow-up care for individuals with pathogenic variants is logistically challenging and results in poor guideline adherence. To address this challenge, authors created clinical management strategies for individuals identified at high risk for hereditary cancers.MethodsAn implementation mapping approach was used to develop and evaluate the establishment of a Hereditary Cancer Clinic at the Medical University of South Carolina throughout in 2022. This approach consisted of 5 steps: conduct a needs assessment, identify objectives, select implementation strategies, produce implementation protocols, and develop an evaluation plan. The needs assessment consisted of qualitative interviews with patients (n=11), specialists (n=9), and members of the implementation team (n=4). Interviews were coded using the Consolidated Framework for Implementation Research to identify barriers and facilitators to establishment of the Hereditary Cancer Clinic. Objectives were identified, and then the team selected implementation strategies and produced implementation protocols to address concerns identified during the needs assessment. Authors conducted a second round of patient interviews to assess patient education materials.ResultsThe research team developed a long-term evaluation plan to guide future assessment of implementation, service, and clinical/patient outcomes.ConclusionsThis approach provides the opportunity for real-time enhancements and impact, with strategies for care specialists, patients, and implementation teams. Findings support ongoing efforts to improve patient management and outcomes while providing an opportunity for long-term evaluation of implementation strategies and guidelines for patients at high risk for hereditary cancers.Copyright © 2023 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.

17 keywords...

hide…